2
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
7
Neoplasms
3
Lung Neoplasms
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pleural Effusion
1
Pituitary Diseases
1
Pituitary ACTH Hypersecretion
1
Obesity
1
Myasthenia Gravis
1
Motor Activity
1
Lymphoma
1
Kidney Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Cardiotoxicity
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Adenocarcinoma of Lung
1
ACTH-Secreting Pituitary Adenoma
1
Interventions
Docetaxel
292
Prednisone
241
enzalutamide
195
Leuprolide
185
Radiotherapy
179
Abiraterone Acetate
170
Magnetic Resonance Spectroscopy
163
bicalutamide
141
Goserelin
138
Androgen Antagonists
121
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
108
Radiosurgery
108
apalutamide
93
abiraterone
83
gallium 68 PSMA-11
81
Specimen Handling
73
darolutamide
67
Surveys and Questionnaires
64
Gonadotropin-Releasing Hormone
63
Triptorelin Pamoate
58
Radiation
57
Biopsy
57
Brachytherapy
54
cabazitaxel
53
Standard of Care
51
Radiotherapy, Intensity-Modulated
51
Zoledronic Acid
50
pembrolizumab
49
luprolide acetate gel depot
49
Flutamide
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Biomarkers
×
Clear all
NCT01838265
2014-12-08
MGM
University of Miami
Withdrawn